The Latest Breaking News from Cronos Group Inc

CRON, DOLE or MOS: Which Agriculture Stock Is Set to Bloom?

Despite economic challenges, the agricultural sector is set to stay strong with ongoing government support, advanced technology integration, and a focus on innovation aimed toward operational efficiency. In light of these industry tailwinds, which agricultural stock among Cronos Group (CRON), The Mosaic Company (MOS), and Dole plc (DOLE) is most…

StockNews.com · Nov 30, 2023

2 Agriculture Stocks to Buy in August 2023, 1 to Sell

The agriculture industry is well-positioned for solid growth thanks to the rise in global population, and robust demand for food. To that end, buying fundamentally strong agriculture stocks Archer-Daniels-Midland (ADM) and AGCO Corporation (AGCO) could be wise. However, it could be wise to sell Cronos Group (CRON), given its weak…

StockNews.com · Aug 2, 2023

Should You Buy Shares of Cronos Group (CRON) in July?

Cannabis producer Cronos Group (CRON) is experiencing turbulent times with weakening sales and losses. So, will it be worth investing in the stock now? Read on.

StockNews.com · Jul 4, 2023

Cronos Q3 Revenue Stagnates, Remains On Track For $20M In Operating Expense Savings

Cronos Group Inc. (NASDAQ: CRON) (TSX:CRON) Q3 2022 net revenue was $20.9 million, a 2.5% increase compared to $20.4 million in Q3 2021.

Benzinga · Nov 7, 2022

Cronos Q2 2022 Revenue Grows 47% YoY, Company Focused On Rare Cannabinoids

Cronos Group Inc. (NASDAQ: CRON) (TSX:CRON) released its 2022 second quarter business results, revealing gross profit of $4.1 million in Q2 2022 improved by $19.9 million from Q2 2021.

Benzinga · Aug 9, 2022

Cronos Partners With Geocann To Launch CBD Gel Capsules By Lord Jones Utilizing VESIsorb For Faster Absorption

Cronos Group Inc. (NASDAQ: CRON) (TSX:CRON) launched the first of what is expected to be a range of products, in partnership with Geocann, which will utilize the VESIsorb delivery system.

Benzinga · Jun 27, 2022

Why Ginkgo Bioworks Shares Are Rising After Announcement With Partner Cronos Group

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher by 7.63% to $2.68 after the company, and Cronos Group Inc (NASDAQ: CRON), announced the achievement of the third target productivity milestone in their par

Benzinga · Jun 23, 2022

Cronos Q1 Revenue Improves 101.61% YoY, Cannabis Company Attributes Growth To This

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) reported Tuesday its 2022 first quarter business results with net revenue growth of 101.61% year-over-year, due to the revenue improvements in the Israeli medical market and the Canadian adult-use market.

Benzinga · May 10, 2022

Here's Why Aurora Cannabis, Canopy Growth, Cronos Group, Sundial Growers And Tilray Shares Are Falling

Shares of many cannabis stocks, including Aurora Cannabis Inc (NASDAQ: ACB), Canopy Growth Corp (NASDAQ: CGC), Cronos Group Inc (NASDAQ:

Benzinga · Mar 28, 2022

Here's Why Aurora Cannabis, Canopy Growth, Cronos Group, Sundial Growers And Tilray Shares Are Rising

Shares of several cannabis stocks, including Aurora Cannabis Inc (NASDAQ: ACB), Canopy Growth Corp (NASDAQ: CGC), Cronos Group Inc (NASDAQ:

Benzinga · Mar 25, 2022